Subscribe To

Price Alert Latest News Economic Calendar News

SOPH / SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023

BOSTON & LAUSANNE, Switzerland--(BUSINESS WIRE)---- $SOPH--SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open on Tuesday, March 7, 2023. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. EST / 2:00 p.m. CET. Read More

Demo Live Account See Partner Details

Content Topics

Sophia

Genetics

Announce

Financial

Results

Fourth

Quarter

Fiscal

Stock

SOPH

Posted: Feb 23 2023, 16:40

Author Name: Business Wire

SOPH News

By GlobeNewsWire
October 24, 2023

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023

BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in d

By Seeking Alpha
August 12, 2023

SOPHiA GENETICS SA (SOPH) Q2 2023 Earnings Call Transcript

SOPHiA GENETICS SA (NASDAQ:SOPH ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Katherine Bailon - Head, Investor Re

By Seeking Alpha
May 13, 2023

SOPHiA GENETICS SA (SOPH) Q1 2023 Earnings Call Transcript

SOPHiA GENETICS SA (NASDAQ:SOPH ) Q1 2023 Earnings Conference Call May 9, 2023 8:00 AM ET Company Participants Katherine Bailon - Vice President of In

By GlobeNewsWire
April 25, 2023

SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023

BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare s

By Zacks Investment Research
March 17, 2023

SOPHiA GENETICS SA (SOPH) Surges 13.0%: Is This an Indication of Further Gains?

SOPHiA GENETICS SA (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might he

By Zacks Investment Research
March 16, 2023

SOPHiA GENETICS SA (SOPH) Just Flashed Golden Cross Signal: Do You Buy?

Is it a good or bad thing when a stock experiences a golden cross technical event?

By Seeking Alpha
March 7, 2023

SOPHiA GENETICS SA (SOPH) Q4 2022 Earnings Call Transcript

SOPHiA GENETICS SA (NASDAQ:SOPH ) Q4 2022 Results Earnings Conference Call March 7, 2023 8:00 AM ET Company Participants Katherine Bailon - Vice Presi

By Zacks Investment Research
March 7, 2023

SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates

SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of 35.29% and 3.55%, respectively, for the quarter ended December 2022. Do the numb

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.